A risk-benefit assessment of drugs used in the eradication of Helicobacter pylori infection.

Hackelsberger, A

A risk-benefit assessment of drugs used in the eradication of Helicobacter pylori infection. [electronic resource] - Drug safety Jul 1996 - 30-52 p. digital

Publication Type: Journal Article; Review

0114-5916

10.2165/00002018-199615010-00003 doi


Amoxicillin--administration & dosage
Anti-Bacterial Agents--therapeutic use
Bismuth--therapeutic use
Clarithromycin--administration & dosage
Drug Therapy, Combination
Dyspepsia--microbiology
Helicobacter Infections--drug therapy
Helicobacter pylori--drug effects
Histamine H2 Antagonists--therapeutic use
Humans
Nitroimidazoles--therapeutic use
Omeprazole--administration & dosage
Penicillins--therapeutic use
Peptic Ulcer--microbiology
Proton Pump Inhibitors
Risk Assessment
Tetracyclines--therapeutic use